| Barrow Neurological Institute | |
|---|---|
| Logo placeholder | |
| Location | Phoenix, Arizona, USA |
| Type | Neurological Research Institute |
| Founded | 1962 |
| Website | https://www.barrowneuro.org |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, ALS, Movement Disorders, Neuroscience |
| Affiliation | St. Joseph's Hospital and Medical Center |
The Barrow Neurological Institute (BNI) is one of the largest neurological disease research and treatment centers in the United States. Located in Phoenix, Arizona, Barrow is affiliated with St. Joseph's Hospital and Medical Center and is internationally recognized for its groundbreaking work in neurosurgery, neurology, and neuroscience research[1].
Founded in 1962, Barrow has grown from a small neurosurgery center into one of the world's premier neurological institutes, treating over 75,000 patients annually and conducting groundbreaking research in neurosurgery, neurology, and neuroscience. The institute houses specialized centers for neurodegenerative disease research, including the renowned Muhammad Ali Parkinson Center.
The Barrow Neurological Institute was founded in 1962 by Dr. Charles E. Brackett, who named it after his mentor, Dr. John Barrow. Originally a small neurosurgery center, Barrow has grown into one of the world's premier neurological institutes[1:1].
The Muhammad Ali Parkinson Center was established in 1997 with boxing legend Muhammad Ali as its founding champion, becoming one of the most comprehensive Parkinson's disease treatment and research centers in the world. The center provides:
Barrow maintains a comprehensive Alzheimer's disease research program[2]:
The movement disorders program encompasses[5]:
Barrow researchers investigate[7]:
Research programs include[8]:
Barrow conducts research on[9]:
A premier Alzheimer's research and clinical care facility focusing on:
Comprehensive PD treatment and research including:
Stroke and vascular dementia research:
Brain tumors and neurological complications research
Barrow offers extensive training opportunities in neurology and neurosurgery:
Barrow researchers have contributed significant discoveries:
Barrow has announced major initiatives in:
Barrow Neurological Institute Annual Research Report 2025. 2025. ↩︎ ↩︎
Sabbagh MN, et al. Alzheimer's disease prevention: current approaches and future directions. Nature Reviews Neurology. 2023. ↩︎ ↩︎
Ringman JM, et al. Biomarkers for Alzheimer's disease in clinical practice. JAMA Neurology. 2022. ↩︎
Chen X, et al. Tau PET imaging in Alzheimer's disease. Brain. 2023. ↩︎
Kalia LV, Lang AE. Parkinson's disease: new therapeutic strategies. Lancet. 2023. ↩︎
Espay AJ, et al. Deep brain stimulation in Parkinson's disease: optimal targets. Annals of Neurology. 2022. ↩︎ ↩︎
Ostrow LW, Lomen-Hoerth C. Amyotrophic lateral sclerosis: clinical features and pathogenesis. Nature Reviews Neurology. 2023. ↩︎
Doppel L, et al. Multiple system atrophy: emerging biomarkers and therapies. Movement Disorders. 2023. ↩︎
Marder K, et al. Frontotemporal dementia: updates on classification and genetics. Nature Reviews Neurology. 2023. ↩︎
Bernstock JD, et al. Neurodegeneration and neuroinflammation: emerging therapeutic targets. Nature Reviews Neurology. 2024. ↩︎
Reach IS, et al. Neurodegenerative disease biomarkers in blood. Nature Reviews Neurology. 2022. ↩︎
Masdeu JC, et al. Neuroimaging biomarkers in neurodegenerative diseases. Radiology. 2022. ↩︎